Epinastine Ophthalmic Drops, Solution 0.05pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Epinastine: Ophthalmic drops, solution (0.05%)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file default-drug-image.png
Epinastine 0.05% Ophth Soln
Drug Image file default-drug-image.png
Epinastine 0.05% Ophth Soln
Drug Image file default-drug-image.png
Epinastine 0.05% Ophth Soln

What is this Medicine?

EPINASTINE (ep i NAS tine) is an antihistamine for use in the eye. It is used to prevent itching of the eye caused by allergies.

CVS Pharmacy Patient Statistics for Epinastine: Ophthalmic drops, solution(0.05%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Epinastine Hydrochloride 0.05% Ophthalmic Solution

NDC: 519910836
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Allergic Conjunctivitis, Ocular Pruritus

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Epinastine Hydrochloride 0.05% Ophthalmic Solution
Close All Sections Show

Reported Side Effects for Epinastine Hydrochloride 0.05% Ophthalmic Solution

Close Show
Cough Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Itchy Eyes Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Sore Throat Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
1.0-3.0%*
Severity: MILD
Onset: DELAYED
Engorgement With Blood Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Eye Irritation Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Rhinitis Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
10.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Close Show
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Epinastine

Close Show

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.